| | ANDA Number | Generic Drug Name | Applicant | Tentative Approval Date |
| 1 | 77-345 | SERTRALINE HYDROCHLORIDE TABLETS, 25 MG (BASE), 50 MG (BASE), AND 100 MG (BASE) | PUREPAC PHARMACEUTICAL COMPANY | 12/6/2005 |
| 2 | 76-748 | ROSIGLITAZONE MALEATE TABLETS, 2 MG (BASE), 4 MG (BASE), AND 8 MG (BASE) | DR. REDDY'S LABORATORIES LIMITED | 12/7/2005 |
| 3 | 77-129 | RIVASTIGMINE TARTRATE CAPSULES, 1.5 MG (BASE), 3 MG (BASE), 4.5 MG (BASE), AND 6 MG (BASE) | WATSON LABORATORIES, INC. | 12/7/2005 |
| 4 | 77-376 | MIRTAZAPINE ORALLY DISINTEGRATING TABLETS, 45 MG | AUROBINDO PHARMA LIMITED | 12/8/2005 |
| 5 | 76-798 | PIOGLITAZONE HYDROCHLORIDE TABLETS, 15 MG (BASE), 30 MG (BASE), AND 45 MG (BASE) | WATSON LABORATORIES, INC. | 12/13/2005 |
| 6 | 77-136 | TERBINAFINE HYDROCHLORIDE TABLETS, 250 MG (BASE) | GENPHARM INC. | 12/13/2005 |
| 7 | 76-596 | MODAFINIL TABLETS, 100 MG AND 200 MG | TEVA PHARMACEUTICALS USA | 12/16/2005 |
| 8 | 77-299 | SERTRALINE HYDROCHLORIDE TABLETS, 25 MG (BASE), 50 MG (BASE), AND 100 MG (BASE) | PLIVA HRVATSKA D.O.O. | 12/21/2005 |
| 9 | 77-363 | RIVASTIGMINE TARTRATE ORAL SOLUTION, 2 MG (BASE)/ML | RANBAXY INC. | 12/21/2005 |
| 10 | 77-774 | STAVUDINE FOR ORAL SOLUTION USP, 1 MG/ML | AUROBINDO PHARMA LIMITED | 12/21/2005 |
| 11 | 76-442 | SERTRALINE HYDROCHLORIDE TABLETS, 25 MG (BASE), 50 MG (BASE), AND 100 MG (BASE) | DR. REDDY'S LABORATORIES LIMITED | 12/27/2005 |
| 12 | 77-221 | LAMIVUDINE TABLETS, 150 MG AND 300 MG | WATSON LABORATORIES, INC. | 12/27/2005 |
| 13 | 77-378 | CARVEDILOL TABLETS, 3.125 MG | CARACO PHARMACEUTICAL LABORATORIES, LTD. | 12/27/2005 |
| 14 | 77-702 | NEVIRAPINE ORAL SUSPENSION, 50 MG/5 ML | AUROBINDO PHARMA LIMITED | 12/29/2005 |
| 15 | 77-335 | FINASTERIDE TABLETS USP, 1 MG | WATSON LABORATORIES, INC. | 12/29/2005 |
| 16 | 76-532 | SIMVASTATIN TABLETS USP, 5 MG, 10 MG, 20 MG, 40 MG, AND 80 MG | TEVA PHARMACEUTICALS USA | 12/30/2005 |